Patronage of Nigerian-made drugs will drive job creation, enables affordability – PMG-MAN

Patronage of Nigerian-made drugs will drive job creation, enables affordability – PMG-MAN

The Pharmaceutical Manufacturers Group of Manufacturers Association of Nigeria (PMG-MAN), has challenged Nigerians to patronize made in Nigeria medicines for more job opportunities.

The association noted that when locally made drugs are patronized, it will encourage them to produce it in larger quantities, thereby making it more affordable to poor masses..

Executive Secretary of the group, Mr Frank Mounemeh, while speaking to NHO in an interview regretted that Nigerians don’t believe in themselves or their capacities. 

He said: “For us in the industry, the local pharma, we’ve been holding forth as patriots because we all know the challenges we face in Nigeria.

“If you are a manufacturer, you could have looked the other way to be an importer but we say no, because our vision has always been to close the gaps in the access to medicine and help the country attain medicine security.

“We are aware of the challenge of medicine inequity, Nigerians cannot access medicine or vaccine as it supposed to, but the only way you can close those gaps is when you build capacity and you start by believing in yourself.

He, however, appreciated those who have kept faith in the local manufacturers.

Mounemeh said: “It is only when people buy made in Nigerian medicine, that’s when we create jobs, that’s when we produce the pressure that we put on forest.

“That’s when we could continue to make medicine affordable and accessible to every Nigerian,” Mounemeh said.

He stated: “As we evolve, one thing that is key is that we’ve come to a point of self realization that we can do things on our own, over time, that has always been the challenge.”

.

 

About author

You might also like

BREAKING NEWS 0 Comments

No killer anti-malaria drug in Nigeria – NAFDAC

• Says Senate’s list of 42 drugs banned by EU are monotherapies already phased out in the country The National Agency for Food Drug Administration and Control (NAFDAC) today reacted

WORLD NEWS 1Comments

WHO rescinds Mugabe’s appointment as NCDs goodwill ambassador

The World Health Organization (WHO) Director General,  Dr. Tedros Adhanom Ghebreyesus,  on Sunday reversed his decision to name Zimbabwe’s President Robert Mugabe as a goodwill ambassador, following widespread uproar against

Merck, Pfizer, Syndax Collaborate to evaluate combination drug for ovarian cancer

Multinational pharmaceutical companies, Merck, Pfizer and Syndax Pharmaceuticals, Inc. have entered into a collaboration agreement to evaluate avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, in combination with Syndax’s

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply